Table 2.
Characteristics | Postoperative sexual impairment: No (n=22; 68.8%) | Postoperative sexual impairment: Yes (n=10; 31.3%) | P |
---|---|---|---|
Age at surgery (year) | |||
Median | 30 | 29 | 0.2 |
Range | 27–36 | 27–30 | |
BMI (kg m−2) | |||
Median | 24 | 24 | 0.4 |
Range | 23–26 | 21–25 | |
Number of LN removed | |||
Median | 17 | 16 | 0.9 |
Range | 11–21 | 12–19 | |
Preoperative IIEF-5 | |||
Median | 25 | 25 | 0.7 |
Range | 20–25 | 19–25 | |
Scholar status, n (%) | 0.4 | ||
University | 7 (31.8) | 5 (50.0) | |
High school | 10 (45.5) | 5 (50.0) | |
Primary school | 4 (18.2) | 0 (0) | |
Unknown | 1 (4.5) | 0 (0) | |
Preoperative sexual impairment, n (%) | 1 | ||
No | 19 (86.4) | 9 (90.0) | |
Yes | 3 (13.6) | 1 (10.0) | |
Preoperative RFs, n (%) | 0.6 | ||
No | 5 (22.7) | 4 (40.0) | |
Yes | 17 (77.3) | 6 (60.0) | |
Preoperative RF categories, n (%) | 0.2 | ||
None | 5 (22.7) | 4 (40.0) | |
Diabetes/metabolic syndrome | 0 (0) | 0 (0) | |
Neuroleptics/antiepileptic | 0 (0) | 1 (10.0) | |
Smoke | 4 (18.2) | 2 (20.0) | |
Alcohol | 10 (45.5) | 1 (10.0) | |
Smoke and alcohol | 3 (13.6) | 2 (20.0) | |
Preoperative spermiogram, n (%) | 0.2 | ||
Altered | 3 (13.6) | 0 (0) | |
Normal | 13 (59.1) | 9 (90.0) | |
Unknown | 6 (27.3) | 1 (10.0) | |
Type of RPLND, n (%) | 0.08 | ||
Postchemotherapy | 8 (36.4) | 0 (0) | |
Simple | 14 (63.6) | 10 (100) | |
Year of surgery group | 0.9 | ||
2012–2016 | 11 (50.0) | 6 (60.0) | |
2017–2020 | 11 (50.0) | 4 (40.0) | |
Patients’ positioning, n (%) | 0.7 | ||
Full flank | 8 (36.4) | 2 (20.0) | |
Supine | 14 (63.6) | 8 (80.0) | |
Laterality, n (%) | 0.3 | ||
Left | 7 (31.8) | 6 (60.0) | |
Right | 15 (68.2) | 4 (40.0) | |
Adjuvant chemotherapy, n (%) | 0.8 | ||
No | 20 (90.9) | 8 (80.0) | |
Yes | 2 (9.1) | 2 (20.0) |
BMI: body mass index; IIEF-5: International Index of Erectile Function-5; RPLND: retroperitoneal lymph node dissection; RFs: risk factors; LN: lymph node